Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients.
Fort Lee, NJ
Joined September 2022
- Tweets461
- Following19
- Followers232
- Likes29
As the global oncology community gathers in Madrid from October 23–27, the Elevar Therapeutics team is looking forward to connecting with fellow innovators, clinical investigators, and partners who share our passion for transforming cancer care.
If you are attending, we invite you to stop by Booth #1085 at IFEMA MADRID!
Our team will be available to discuss Elevar's oncology programs, scientific research activities, and commitment to advancing treatment options and Elevating Outcomes for cancer patients.
#ElevarTx #ElevarTherapeutics #ESMO2026
Did you know?
An estimated 110K+ people are currently living with liver and intrahepatic bile duct cancer.
This October, Elevar joins the community in support of National Liver Awareness Month and all those living with a liver disease.
elevartx.com/
#ElevarTx #ElevarTherapeutics #LiverCancerAwarenessMonth #LiverCancer
Elevar Therapeutics is excited to announce that our team will be heading to Madrid, Spain for the ESMO Congress 2026, hosted by the European Society for Medical Oncology from October 23–27!
As one of the world's most influential global oncology platforms, ESMO is an incredible environment to connect with leading international researchers, clinical investigators, and industry innovators who are collectively driving breakthroughs in cancer care.
#ElevarTx #ElevarTherapeutics #ESMO2026
Elevar Therapeutics is proud to announce that we are in Grapevine, Texas for the 8th Annual Cholangiocarcinoma Summit from October 15-16!
This year’s summit holds immense significance for our entire organization following the recent FDA approval of Lyrfigtu™ (lirafugratinib) as a targeted treatment option for patients facing FGFR2-driven cholangiocarcinoma.
We are incredibly eager to join leading clinical experts, researchers, patient advocates, and industry peers to dive into the latest therapeutic advancements, clinical data, and collaborative strategies shaping the future of biliary tract cancer care. For Elevar, every conversation at #CCASummit2026 is an opportunity to strengthen the care ecosystem and further our mission of Elevating Outcomes for patients who have historically faced limited options.
#ElevarTx #ElevarTherapeutics
Today, Elevar Therapeutics recognizes Indigenous Peoples’ Day, a time to honor the invaluable contributions, vibrant cultures, and enduring histories of Indigenous communities across the nation and the globe.
At Elevar, our foundational mission is Elevating Outcomes for patients who have limited or inadequate treatment options.
Join us in celebrating the rich heritage of Indigenous peoples and working toward a healthier, more equitable future for all.
#IndigenousPeoplesDay #ElevarTx #ElevarTherapeutics
On World Mental Health Day, Elevar Therapeutics joins the global community in advocating for mental well-being, reducing stigma, and recognizing the profound emotional toll that chronic and advanced illnesses can take on individuals.
Today, we also pause to honor and support our own team members, partners, and healthcare providers. Cultivating a supportive culture where mental well-being is prioritized allows us to show up fully every day for the patients who depend on us.
Let's prioritize empathy, advocate for robust psychological support systems, and check in on one another today and every day.
#WorldMentalHealthDay #ElevarTx #ElevarTherapeutics
Next stop: New York City!
Elevar Therapeutics is proud to participate in the Association for Value-Based Cancer Care (AVBCC) 16th Annual Summit from October 7–9!
True innovation in oncology goes beyond clinical breakthroughs in the lab; it requires active collaboration with C-suite leaders and stakeholders across the healthcare ecosystem to close the gaps between the cost and quality of care.
We look forward to joining nationally recognized oncology experts to tackle the critical issues shaping the future of market access, health policy, and oncology specialty pharmacies. For our team, these conversations are vital as we continue our mission of Elevating Outcomes and driving forward meaningful patient access to therapies for complex cancers.
#AVBCC2026 #ElevarTx #ElevarTherapeutics
Elevar Therapeutics is excited to attend the Cencora Oncology Exchange Fall meeting from October 2-3!
This event comes at an incredibly meaningful time for our team following the recent FDA approval of Lyrfigtu™ (lirafugratinib). We are looking forward to engaging in robust clinical discussions, sharing insights from our pipeline, and exploring new avenues of collaboration to support the community oncology ecosystem.
At Elevar, we are deeply committed to Elevating Outcomes. Collaborative environments like this inspire us to keep pushing the boundaries of what is possible for cancer patients.
#ElevarTx #ElevarTherapeutics #CencoraOncologyExchange
October is Liver Cancer Awareness Month, a crucial time to elevate awareness, emphasize early detection, and reaffirm our commitment to transforming the lives of patients facing advanced liver diseases.
At Elevar Therapeutics, we are deeply dedicated to "Elevating Outcomes" for patients and families affected by complex liver conditions. True innovation requires a dual commitment: pushing the boundaries of clinical research to develop next-generation combination therapies while building robust awareness around prevention and early intervention.
This month, we also want to shine a bright spotlight on the unsung heroes, the clinicians, researchers, care teams, and families, who make a difference every single day in the oncology community.
#LiverCancerAwarenessMonth #ElevarTx #ElevarTherapeutics
Fueling innovation and promoting health, one cup at a time. Happy National Coffee Day from the Elevar Therapeutics team!
In the world of oncology and life sciences, our morning brew is more than a routine; it is a catalyst for breakthroughs. But did you know your favorite morning beverage may also be a powerful ally in liver health?
A major long-term study published in Clinical Gastroenterology and Hepatology found that drinking coffee is associated with a 47% lower risk
of developing liver cancer and a 32% lower risk of cirrhosis.
At Elevar, our focus is on advancing therapies that transform patient outcomes. On National Coffee Day, we celebrate the small daily habits, and the big scientific discoveries, that keep our team and community healthy.
#NationalCoffeeDay #ElevarTx #ElevarTherapeutics
Ref: lnkd.in/gAE3ZemK
Elevar Therapeutics is proud to announce our attendance at the Cholangiocarcinoma Foundation (CCF) Symposium.
Our team is dedicated to advancing therapeutic options for patients facing gastrointestinal cancers. We look forward to connecting with leading clinicians, researchers, and patient advocates to discuss the latest breakthroughs and collaborative opportunities in the field.
#CCFSymposium #ElevarTx #Cholangiocarcinoma #CancerResearch #Oncology #ElevarTherapeutics
Breaking news! The FDA has approved our treatment for patients with previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma (CCA) harboring a FGFR2 fusion or other rearrangement.
Read our #ElevarPressRelease: elevartx.com/2026/09/23/elev…
#ElevarTx #ElevarTherapeutics #ElevatingOutcomes #news
Knowledge of specific genomic alterations, such as Fibroblast Growth Factor Receptor (FGFR)2 fusions or rearrangements, can transform the management of cholangiocarcinoma (CCA) because potent and specific anti-cancer drugs might be available to prolong lives of patients with specific genetic alterations. At Elevar Therapeutics, we recommend comprehensive molecular testing early in the diagnostic journey to help match appropriate targeted therapies to individual patient profiles.
#ElevarTx #ElevarTherapeutics #MutationTesting
While usually diagnosed in people over 60, cholangiocarcinoma is increasing across all age groups, including younger people, and the cause of this rise is currently unknown. The incidence and mortality rate in North America have increased dramatically in past decades.
#CCAawareness #ElevarTx #ElevarTherapeutics #RareCancer #CancerResearch
Hello from the DAVA Oncology Summit in Bermuda!
The Elevar Therapeutics team is on-site connecting with global key opinion leaders, clinical researchers, and oncology advocates.
We are here to dive into emerging data, discuss cutting- edge treatment strategies, and share insights on advancing therapies for complex, underserved cancers.
Collaborations forged at scientific exchanges like DAVA are essential for accelerating clinical trial timelines and ultimately elevating treatment experiences for patients worldwide.
#DAVAOncology #ElevarTx #ElevarTherapeutics #CancerResearch
